bempegaldesleukin,Nivolumab,Sunitinib,Cabozantinib
Nektar,BMS,Pfizer,Exelixis
['nivo', 'sunitinib', 'bempeg', 'cabozantinib', 'aldesleukin', 'nivolumab', 'renal,(-adrenal)', 'pivot,9']
the pivot-09 study, presented by our dr. nizar tannir, compared bempegaldesleukin plus nivolumab to the investigator's choice of sunitinib or cabozantinib in previously untreated patients with advanced renal cell carcinoma: #esmo22 #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789